Editorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsored

FDA-approved · 2022

Mounjaro

Generic: Tirzepatide · Manufactured by Eli Lilly

First dual GLP-1/GIP receptor agonist. Approved for type 2 diabetes, used off-label for weight loss. Generally shows greater weight loss than semaglutide alone.

Avg weight loss

15-22% of body weight

Monthly price

$1,023

With insurance

$25-$200/month with Lilly savings card

Approved

2022

How it works

Mechanism
Dual GLP-1/GIP receptor agonist
Administration
Weekly subcutaneous injection
Doses
2.5mg to 15mg (weekly injection)
Approved for
Type 2 diabetes
Self-pay options
Eli Lilly savings card for eligible patients
Oral version
Injection only

Where to get Mounjaro online

The 5 top-rated providers we’ve reviewed that prescribe Tirzepatide.